Malta vs Sur: Previously treated cases tested for RR-/MDR-TB
Malta
100.0%
in 2022
Sur
62.0%
in 2024
Malta rank
1st
Sur rank
1st
Previously treated cases tested for RR-/MDR-TB over time
- Malta
- Sur
How they compare
Malta currently reports 100.0% against 62.0% in Sur, a difference of 38.0%.
That makes Malta's figure about 1.6 times Sur's.
The two have swapped places 1 time across 6 shared years of data; in 2008 it was Sur ahead.
Malta ranks 1st and Sur ranks 1st of 180 countries.
Malta has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Malta | Sur | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 21.5% | 21.5% | 0.0% | — |
| 2010s | 66.7% | 27.0% | 39.7% | Malta |
| 2020s | 100.0% | 80.0% | 20.0% | Malta |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Malta or Sur?
- Malta, at 100.0% against 62.0% in Sur as of 2022.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Malta and Sur?
- 38.0%, with Malta ahead.
- How many years of comparable data are there for Malta and Sur?
- 6 years are reported by both, from 2008 to 2022.
- How do Malta and Sur rank globally for previously treated cases tested for rr-/mdr-tb?
- Malta ranks 1st and Sur ranks 1st of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.